Hypoglycemic therapy in patients with type 2 diabetes and chronic heart failure

Hypoglycemic therapy in patients with type 2 diabetes and chronic heart failure

The article presents a literature review of prevalence, prognosis and treatment of overt tactics of chronic heart failure (CHF) in patients with type 2 diabetes mellitus (T2DM). Application of modern pharmacological preparations and instrumental treatment of cardiovascular disease (CVD) increases li...

Full description

Bibliographic Details
Main Authors:	S. V Kakorin, I. A Averkova, A. M Mkrtumyan
Format:	Article
Language:	English
Published:	Concilium Medicum 2014-03-01
Series:	КардиоСоматика
Subjects:	type 2 diabetes chronic heart failure (chf) cardiovascular mortality hyperglycemia glycated hemoglobin insulin resistance (ir) hyperinsulinemia metformin sulfonylurea medications insulin
Online Access:	https://cardiosomatics.orscience.ru/2221-7185/article/view/45071

Similar Items

Glycemia control and glucose-lowering therapy in patients with type 2 diabetes mellitus and cardiovascular disease (review of multicenter randomized trials)
by: Sergey V. Kakorin, et al.
Published: (2016-07-01)

Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials
by: Sergey V. Kakorin, et al.
Published: (2016-05-01)

The Negative Impact of Insulin Resistance/Hyperinsulinemia on Chronic Heart Failure and the Potential Benefits of Its Screening and Treatment
by: Serafino Fazio, et al.
Published: (2023-10-01)

Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis
by: Zimo Zhao, et al.
Published: (2023-07-01)

Predetermined Anti-Diabetic Drug Regimen Adjustments during Ramadan Fasting: An Observational Study of Safety
by: Abdallah M. Beano, et al.
Published: (2017-06-01)

THE IMPACT OF AGE-RELATED SARCOPENIA ON SURVIVAL AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE
by: Konstantin D. Gospodinov, et al.
Published: (2022-07-01)

Emerging Links between Cadmium Exposure and Insulin Resistance: Human, Animal, and Cell Study Data
by: Aleksandra Buha, et al.
Published: (2020-08-01)

Hypoglycemic Effect of Resveratrol: A Systematic Review and Meta-Analysis
by: Beatriz Isabel García-Martínez, et al.
Published: (2021-01-01)

Changes in the expression of cancer- and metastasis-related genes and proteins after metformin treatment under different metabolic conditions in endometrial cancer cells
by: Carsten Lange, et al.
Published: (2023-06-01)

Treating Alpelisib-Induced Hyperinsulinemia in Patients with Advanced Breast Cancer – A Real-Life Experience
by: Percik R, et al.
Published: (2023-05-01)

Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia
by: Gebrie D, et al.
Published: (2021-07-01)

Facilitatory effect of insulin treatment on hepatocellular carcinoma development in diabetes
by: Hayato Baba, et al.
Published: (2017-09-01)

Association of Insulin Resistance, Plasma Glucose Level, and Serum Insulin Level With Hypertension in a Population With Different Stages of Impaired Glucose Metabolism
by: Nobuo Sasaki, et al.
Published: (2020-04-01)

Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights
by: George Jia, et al.
Published: (2024-01-01)

Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches
by: A. A. Shchendrygina, et al.
Published: (2021-07-01)

Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
by: Tatiana Ivanovna Romantsova, et al.
Published: (2010-03-01)

Effect of metformin therapy on 2-h post-glucose insulin levels in patients of polycystic ovarian syndrome
by: Pikee Saxena, et al.
Published: (2010-01-01)

Latent autoimmune diabetes of adults: From oral hypoglycemic agents to early insulin
by: Resham R Poudel
Published: (2012-01-01)

Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan
by: Mir Iftikhar Bashir, et al.
Published: (2012-01-01)

Clinical Profiles and Outcomes of Heart Failure in Five African Countries: Results from INTER-CHF Study
by: Kamilu M. Karaye, et al.
Published: (2021-07-01)

Proposal for standardizing normal insulin ranges in Brazilian patients and a new classification of metabolic syndrome
by: Pedro Renato Chocair, et al.
Published: (2022-09-01)

Alpha-Mangostin Improves Cardiac Hypertrophy and Fibrosis and Associated Biochemical Parameters in High-Fat/High-Glucose Diet and Low-Dose Streptozotocin Injection-Induced Type 2 Diabetic Rats
by: Soetikno V, et al.
Published: (2020-01-01)

Burden of Chronic Heart Failure in Romania
by: László Lorenzovici, et al.
Published: (2022-01-01)

Insulin resistance/hyperinsulinemia: an important cardiovascular risk factor that has long been underestimated
by: Serafino Fazio, et al.
Published: (2024-03-01)

Investigating the level of Hba1c and insulin level in β-thalassemia patients
by: Husnan Mujiburrahman, et al.
Published: (2023-12-01)

Comparison of Fasting Insulin Level, Homeostatic Model of Insulin Resistance, and Lipid Levels between Patients with Primary Hypertension and Normotensive Subjects
by: Rithvik Ramesh, et al.
Published: (2022-04-01)

Risk of oncological diseases in patients with diabetes mellitus
by: Gagik Radikovich Galstyan
Published: (2009-12-01)

The use of metformin, sulfonylurea compounds and insulin and the risk of hip fractures in diabetic patients: a systematic review and meta-analysis of observational studies
by: Mansour Bahardoust, et al.
Published: (2023-05-01)

Biochemical Regulation of the Glyoxalase System in Response to Insulin Signaling
by: Der-Yen Lee, et al.
Published: (2021-02-01)

Impact of insulin therapy on the mortality of acute heart failure patients with diabetes mellitus
by: Se Yong Jang, et al.
Published: (2021-09-01)

Association between insulin resistance and the development of cardiovascular disease
by: Valeska Ormazabal, et al.
Published: (2018-08-01)

Development and validation of dietary and lifestyle insulinemic indices among Iranian adult population
by: Ebrahim Mokhtari, et al.
Published: (2022-01-01)

Insulin resistance – the basics every medical specialist should know
by: Jakub Gołacki, et al.
Published: (2022-05-01)

Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis
by: Shu Yi Wang, et al.
Published: (2024-01-01)

Improving outpatient care in chronic heart failure
by: S. A. Boytsov, et al.
Published: (2021-08-01)

Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives
by: Parveena Firdous, et al.
Published: (2018-05-01)

Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes
by: Kiyohiko Takahashi, et al.
Published: (2019-03-01)

REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY"
by: A. A. Aleksandrov
Published: (2016-01-01)

Empagliflozin as a new management strategy on outcomes in patients with type 2 diabetes mellitus
by: Vladimir V. Salukhov, et al.
Published: (2016-12-01)

Fasting Insulin is Better Partitioned according to Family History of Type 2 Diabetes Mellitus than Post Glucose Load Insulin of Oral Glucose Tolerance Test in Young Adults
by: Saritha Francis, et al.
Published: (2017-05-01)